Mandate

Vinge advises SEB, Handelsbanken and Nordea in connection with Trelleborg’s new issue

March 23, 2009

Vinge has advised SEB, Handelsbanken and Nordea in connection with Trelleborg AB’s new issue of shares subject to pre-emption rights for the existing shareholders of approximately SEK 2.2 billion. Trelleborg is listed on NASDAQ OMX Stockholm. The issue is underwritten in its entirety by Trelleborg’s major shareholders, certain other interested parties and SEB, Handelsbanken, Nordea and DnB NOR. SEB, Handelsbanken, Nordea and DnB NOR have undertaken to underwrite approximately SEK 900 million which thus comprises approximately 40 per cent of the new issue. The detailed terms and conditions governing the new issue including the subscription price will be determined and communicated on 21 April 2009.

Ola Sandersson and Dain Nevonen advised SEB, Handelsbanken and Nordea.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026